GeoVax Labs (QB) Stock Price

0.012 (4.0%)
Best deals to access real time data!
DDE w/Realtime (Monthly)
Monthly Subscription
for only
Small Cap Pro
Monthly Subscription
for only
Canna Trader Pro
Monthly Subscription
for only
VAT not included
Company Name Stock Ticker Symbol Market Type
GeoVax Labs Inc (QB) GOVX OTCMarkets Common Stock
  Price Change Change Percent Stock Price Last Traded
0.012 4.0% 0.312 16:28:29
Close Price Low Price High Price Open Price Previous Close
0.312 0.30 0.33 0.33 0.30
Bid Price Ask Price Spread News
0.29 0.3668 0.0768 - -
Stock Trades Traded Volume VWAP Dollar Volume Average Volume 52 Week Range
90 122,771 $ 0.310198 $ 38,083 497,493 0.0003 - 1.75
Last Trade Time Type Quantity Stock Price Currency
15:53:55 375 $ 0.312 USD

GeoVax Labs (QB) Financials

Market Cap Shares in Issue Float Revenue Profit/Loss EPS PE Ratio
$ 4.82M 15.44M 13.78M $ - $ - - -
Short Interest Dividends Per Share Dividend Yield Ex-Div Date Insider B/S Insider % Owned
10.04k $ - 0.00% - -

more financials information »

GeoVax Labs (QB) News

Loading Messages....

{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....

No posts yet, be the first! No {{symbol}} Message Board. Create One! See More Posts on {{symbol}} Message Board See More Message Board Posts

Historical GOVX Price Data

Period † Open High Low VWAP Avg. Daily Vol Change %
1 Week0.320.3650.2750.3098961494,232-0.008-2.5%
1 Month0.500.540.2750.3731662292,084-0.188-37.6%
3 Months0.391.750.2750.7611042540,262-0.078-20.0%
6 Months0.2851.750.17610.5569577489,7570.0279.47%
1 Year0.0121.750.00030.02406459,246,6940.302,500.0%
3 Years0.041.750.00030.02621883,706,2180.272680.0%
5 Years0.13031.750.00030.02781992,272,4010.1817139.45%

GeoVax Labs (QB) Description

GeoVax Labs, Inc. is a clinical-stage biotechnology company developing human vaccines against infectious diseases using our Modified Vaccinia Ankara - Virus-Like Particle (MVA-VLP) vaccine platform. Our current development programs are focused on preventive vaccines against COVID-19, HIV, Zika virus, Hemorrhagic Fever viruses (Ebola, Sudan, Marburg, Lassa), and malaria, as well as therapeutic vaccines for chronic Hepatitis B infections and cancers. Our vaccine platform supports in vivo production of non-infectious VLPs in the person receiving the vaccine. The production of VLPs in the person being vaccinated mimics virus production in a natural infection, stimulating both the humoral and cellular arms of the ijmmune system to recognize, prevent, and control the target infection.

Your Recent History
GeoVax Lab..
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.